Applied Filters
Japan: DOE and cross-border infringement of a biologics process patent
The Tokyo District Court judgment on patent infringement and question of territoriality is game-changing, says Takanori Abe of Abe & Partners.
When alliances fail, is arbitration the answer?
The global pandemic has increased collaboration and a new wave of disputes is likely. Arbitration is well placed to help, argue Kate Davies McGill, Gaela Gehring Flores and Paul Keller of Allen & Overy
Amendments to Chinese Patents Law for the Life Sciences
Recent changes to patent law in China sees registration, review and litigation fall in line with established international IP systems, say Venable partners Keith Haddaway and Christopher Loh.
COVID-19: Protection of IP for AI tools
As AI becomes a crucial weapon in the battle against the global pandemic, companies in the field need to ensure that their valuable IP is protected, as Mao Xiao Hong and Danny Yap of IPOS International explain.
Agri-patents: The battle of the seeds
An upcoming case on the patent eligibility of genetically modified seed in India will have far-reaching ramifications, as Archana Shankar and Gitika Suri of Anand & Anand explain.
Conference preview: ChinaBio Partnering Forum 2019
The 11th annual ChinaBio Partnering Forum global life science partnering event, which will be held on May 8 and 9 in Shanghai, China, is expected to attract more than 1,400 executives from 500-plus life sciences companies spanning an estimated 25 countries.
A patent attack on three fronts
A recent case in India reveals the various ways in which pharmaceutical patents can be challenged, as Neeti Wilson, Arpita Kulshreshtha and Gitika Suri of Anand and Anand report.
LSIPR 50 2018: Naoko Munakata
Naoko Munakata was selected in the LSIPR 50 2018 publication for her influence on the life sciences industry. She featured in the government and policy section, as LSIPR reports.
LSIPR 50 2018: Changyu Shen
Changyu Shen was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports.
LSIPR 50 2018: Sung Yunmo
Sung Yunmo was selected in the LSIPR 50 2018 publication for his influence on the life sciences industry. He featured in the government and policy section, as LSIPR reports.
